Approval · Notice of Compliance 37062 · 2026
CYSKLAR: Notice of Compliance 37062
Issued March 6, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37062
- Date
- March 6, 2026
- Company
- Leadiant Biosciences, Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSKLAR | 02566524 | Approved |
Medicinal ingredients
- CYSTEAMINE HYDROCHLORIDE 0.44 PER